FleetDrive 360, the provider of a cloud-based solution for managing driver qualifications and compliance, has partnered with Abbott Laboratories to provide carriers with a faster method of scheduling drug tests and 72-hours results returns while maintaining compliance with FMCSA regulations, according to a FleetDrive release.
See also: FleetDrive 360 compliance platform created for larger fleets
“Our integration with Abbott creates a seamless connection for carriers between the lab services provided by one of the nation's largest connected networks and the FleetDrive 360 compliance solution,” said Nic Salis, chief operations officer at FleetDrive 360. “Offering carriers a unique suite of technology-enabled solutions covering all aspects of FMCSA and DOT testing and reporting, and the ability to manage their screening programs, helps our customers get drivers on the road as quickly as possible.”
The FleetDrive 360 automated compliance solution can be accessed on any computer or mobile device. The system also enables API connections for integration with existing transportation management systems and HR platforms.
